Suppr超能文献

Pin1 脯氨酰异构酶对 Fbw7 的稳定性和肿瘤抑制功能的负调控。

Negative regulation of the stability and tumor suppressor function of Fbw7 by the Pin1 prolyl isomerase.

机构信息

Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.

出版信息

Mol Cell. 2012 Jun 29;46(6):771-83. doi: 10.1016/j.molcel.2012.04.012. Epub 2012 May 17.

Abstract

Fbw7 is the substrate recognition component of the Skp1-Cullin-F-box (SCF)-type E3 ligase complex and a well-characterized tumor suppressor that targets numerous oncoproteins for destruction. Genomic deletion or mutation of FBW7 has been frequently found in various types of human cancers; however, little is known about the upstream signaling pathway(s) governing Fbw7 stability and cellular functions. Here we report that Fbw7 protein destruction and tumor suppressor function are negatively regulated by the prolyl isomerase Pin1. Pin1 interacts with Fbw7 in a phoshorylation-dependent manner and promotes Fbw7 self-ubiquitination and protein degradation by disrupting Fbw7 dimerization. Consequently, overexpressing Pin1 reduces Fbw7 abundance and suppresses Fbw7's ability to inhibit proliferation and transformation. By contrast, depletion of Pin1 in cancer cells leads to elevated Fbw7 expression, which subsequently reduces Mcl-1 abundance, sensitizing cancer cells to Taxol. Thus, Pin1-mediated inhibition of Fbw7 contributes to oncogenesis, and Pin1 may be a promising drug target for anticancer therapy.

摘要

Fbw7 是 Skp1-Cullin-F-box(SCF)型 E3 连接酶复合物的底物识别组件,也是一种经过充分研究的肿瘤抑制因子,可靶向多种致癌蛋白进行降解。在各种类型的人类癌症中,经常发现 FBW7 的基因组缺失或突变;然而,关于调节 Fbw7 稳定性和细胞功能的上游信号通路知之甚少。在这里,我们报告 Fbw7 蛋白的破坏和肿瘤抑制功能受到脯氨酰异构酶 Pin1 的负调控。Pin1 以磷酸化依赖的方式与 Fbw7 相互作用,并通过破坏 Fbw7 二聚化来促进 Fbw7 的自我泛素化和蛋白降解。因此,过表达 Pin1 会降低 Fbw7 的丰度,并抑制 Fbw7 抑制增殖和转化的能力。相比之下,在癌细胞中耗尽 Pin1 会导致 Fbw7 表达升高,从而降低 Mcl-1 的丰度,使癌细胞对紫杉醇敏感。因此,Pin1 介导的 Fbw7 抑制有助于肿瘤发生,Pin1 可能是癌症治疗有前途的药物靶点。

相似文献

1
Negative regulation of the stability and tumor suppressor function of Fbw7 by the Pin1 prolyl isomerase.
Mol Cell. 2012 Jun 29;46(6):771-83. doi: 10.1016/j.molcel.2012.04.012. Epub 2012 May 17.
3
Aberrant regulation of FBW7 in cancer.
Oncotarget. 2014 Apr 30;5(8):2000-15. doi: 10.18632/oncotarget.1859.
4
Adenovirus E1A inhibits SCF(Fbw7) ubiquitin ligase.
J Biol Chem. 2009 Oct 9;284(41):27766-27779. doi: 10.1074/jbc.M109.006809. Epub 2009 Aug 13.
5
6
Fbw7α and Fbw7γ collaborate to shuttle cyclin E1 into the nucleolus for multiubiquitylation.
Mol Cell Biol. 2013 Jan;33(1):85-97. doi: 10.1128/MCB.00288-12. Epub 2012 Oct 29.
7
ERK kinase phosphorylates and destabilizes the tumor suppressor FBW7 in pancreatic cancer.
Cell Res. 2015 May;25(5):561-73. doi: 10.1038/cr.2015.30. Epub 2015 Mar 10.
8
SCF(Fbw7) modulates the NFkB signaling pathway by targeting NFkB2 for ubiquitination and destruction.
Cell Rep. 2012 May 31;1(5):434-43. doi: 10.1016/j.celrep.2012.04.002.
9
Prolyl-isomerase Pin1 controls normal and cancer stem cells of the breast.
EMBO Mol Med. 2014 Jan;6(1):99-119. doi: 10.1002/emmm.201302909. Epub 2013 Dec 15.
10
Fbw7 dimerization determines the specificity and robustness of substrate degradation.
Genes Dev. 2013 Dec 1;27(23):2531-6. doi: 10.1101/gad.229195.113.

引用本文的文献

3
FBXW7 in gastrointestinal cancers: from molecular mechanisms to therapeutic prospects.
Front Pharmacol. 2024 Dec 18;15:1505027. doi: 10.3389/fphar.2024.1505027. eCollection 2024.
5
Molecular insights and clinical implications for the tumor suppressor role of SCF E3 ubiquitin ligase.
Biochim Biophys Acta Rev Cancer. 2024 Sep;1879(5):189140. doi: 10.1016/j.bbcan.2024.189140. Epub 2024 Jun 21.
7
The HTLV-I oncoprotein Tax inactivates the tumor suppressor FBXW7.
J Virol. 2024 Jul 23;98(7):e0040524. doi: 10.1128/jvi.00405-24. Epub 2024 Jun 14.
8
The role of the master cancer regulator Pin1 in the development and treatment of cancer.
Front Cell Dev Biol. 2024 Apr 30;12:1343938. doi: 10.3389/fcell.2024.1343938. eCollection 2024.
9
Pin1-Catalyzed Conformation Changes Regulate Protein Ubiquitination and Degradation.
Cells. 2024 Apr 23;13(9):731. doi: 10.3390/cells13090731.
10
Reciprocal antagonism of PIN1-APC/C governs mitotic protein stability and cell cycle entry.
Nat Commun. 2024 Apr 15;15(1):3220. doi: 10.1038/s41467-024-47427-w.

本文引用的文献

2
The glomuvenous malformation protein Glomulin binds Rbx1 and regulates cullin RING ligase-mediated turnover of Fbw7.
Mol Cell. 2012 Apr 13;46(1):67-78. doi: 10.1016/j.molcel.2012.02.005. Epub 2012 Mar 8.
3
Prolyl isomerase Pin1 as a molecular switch to determine the fate of phosphoproteins.
Trends Biochem Sci. 2011 Oct;36(10):501-14. doi: 10.1016/j.tibs.2011.07.001. Epub 2011 Aug 17.
6
A Pin1/mutant p53 axis promotes aggressiveness in breast cancer.
Cancer Cell. 2011 Jul 12;20(1):79-91. doi: 10.1016/j.ccr.2011.06.004.
7
Peptidyl-prolyl cis-trans isomerase Pin1 in ageing, cancer and Alzheimer disease.
Expert Rev Mol Med. 2011 Jun 20;13:e21. doi: 10.1017/S1462399411001906.
8
Death-associated protein kinase 1 phosphorylates Pin1 and inhibits its prolyl isomerase activity and cellular function.
Mol Cell. 2011 Apr 22;42(2):147-59. doi: 10.1016/j.molcel.2011.03.005. Epub 2011 Apr 14.
9
Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7.
Nature. 2011 Mar 3;471(7336):110-4. doi: 10.1038/nature09779.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验